Story excerpt provided by Crain’s Cleveland Business.
Written by Scott Suttell.
Neuros Medical Inc., a nerve stimulation company that just raised $20 million and is finishing a clinical trial involving 130 patients who suffer from post-amputation pain, has a new CEO and plans for a California operation.
The Willoughby-based company on Monday, Aug. 28, announced it has named Tom Wilder as president and CEO.
Wilder has worked in the medical technology industry for more than 30 years, most recently having led Sequent Medical Inc., a neurovascular company that developed the WEB Aneurysm Embolization System, for six years. Sequent was acquired by Terumo Corp. in 2016 for up to $380 million. He previously was president and CEO of PhotoThera Inc., a company that was developing a therapy for acute ischemic stroke patients, and Micro Therapeutics Inc., another neurovascular company.
Click here to read the complete article.
Originally published August 28, 2017.